English: Thank you for the series of questions. I'll start with your first point and your last point together on vaccine supply. It is a UK Government responsibility, and the contracts that they've procured on behalf of the whole of the UK have allowed us to go out and deliver, and it's a credit to the way that our teams in Wales have then used that supply over the last weeks. I think from within your comments there was even some credit for the Government, as well as people outside the Government, for delivering that here in Wales at such a tremendous pace. On vaccine supply, I've spoken not just with Nadhim Zahawi on a regular basis, the UK vaccines Minister, but I've also had conversations with both Pfizer and AstraZeneca and my officials. Pfizer had a planned pause in their production to restart on a more efficient basis. They are confident that that means they will be producing a vaccine at a higher rate, both to meet their commitments with the contract they have with the UK Government for all four nations, and indeed their commitments through Europe. That's good news and they also think that they will be able to negotiate the changed arrangements for goods to transfer between the European Union and the UK, and that of course is hugely important for all of us too. On your point about BME take-up and hesitancy, it is a matter that I have been concerned about from the outset. We're well aware that there is a range of fake news and media associated with a wide group of people across the country. Some of that is particularly targeted around faith communities and around some particular communities, black and Asian-origin communities in particular. So, we're doing work, not just - . Other Governments are also doing something similar as well, in terms of UK-wide messaging, but also, later on today, I'll be joining a round-table with a range of community leaders to help address some of these very points. You'll have heard the comments that I've made and the First Minister has made at yesterday's press conference, indicating how we want to go about making this as open as possible in terms of what the Government does, but also the way that our health boards are doing direct outreach work with some of these communities. And I'm very grateful for individual healthcare staff who are reaching back into their communities to highlight the fact that the vaccine is safe and effective, and there is no bar to them taking it from either a religious or ethnic origin point of view, and that's really, really important for all of us, regardless of our own politics in the Chamber, to get on top of the fake news that will leave people more vulnerable to harm. On second dose plans, that is very much part of what we're doing; you'll see more and more people getting their second doses in the information published every day. You'll also see the rate of second doses going up slightly. We did nearly 700 second doses yesterday and we're soon going to be in the territory of doing thousands of second doses through each week and then tens of thousands as we get to those people who need to have their Pfizer second dose as well. We need to make sure that the stock is available to make sure that we're giving people the right second dose over the weeks ahead. Now, on 70 to 74-year-olds, I haven't given a direction that requires 70 to 74-year-olds to go to a mass vaccination centre. It would probably be more helpful if I could see the correspondence or the suggestion you refer to to try to address it. It's always a possibility that there are anecdotes and a suggestion that the Welsh Government has intervened when we haven't, and I'll be very clear that there is no policy choice that I have made requiring 70 to 74-year-olds to go to a mass vaccination centre. We're operating a deliberately blended approach, with 438 different locations where people can be vaccinated. On your point about people with learning disabilities, it depends whether they're in scope to have a vaccine in the first place, because actually the Medicines and Healthcare products Regulatory Agency authorisation doesn't cover every child, as you'll know, and it's also then about people who are carers and those who are carers within group 6, and those who are older adults with learning disabilities as well. And that very much is part of the challenges that we're considering, both in terms of our interaction with the JCVI and our Welsh representatives on that forum, but also in terms of our broader public health advice as well. In the course of rolling out to group 6 in particular, we will be doing some communications around that and trying to make that as clear as possible, and that'll inform not just what we do as a Government and the interactions health boards have with you, in your local capacities as Members, but obviously I will continue to make that available to health committee members in the regular briefings that we are continuing with. I believe that answers the questions that have been posed at this point.
Welsh: Diolch am y gyfres o gwestiynau. Dechreuaf gyda'ch sylw cyntaf a'ch sylw olaf gyda'i gilydd ar gyflenwi brechlynnau. Mae'n gyfrifoldeb ar Lywodraeth y DU, ac mae'r contractau y maen nhw wedi'u caffael ar ran y DU gyfan wedi caniatáu i ni gyflawni, ac mae'n glod i'r ffordd y mae ein timau yng Nghymru wedi defnyddio'r cyflenwad hwnnw dros yr wythnosau diwethaf. Credaf o'ch sylwadau fod hyd yn oed rhywfaint o glod i'r Llywodraeth, yn ogystal â phobl y tu allan i'r Llywodraeth, am gyflawni hynny yma yng Nghymru mor aruthrol o gyflym. O ran y cyflenwad o frechlynnau, rwyf wedi siarad nid yn unig â Nadhim Zahawi yn rheolaidd, Gweinidog brechlynnau'r DU, ond rwyf hefyd wedi cael sgyrsiau gyda Pfizer ac AstraZeneca a'm swyddogion. Roedd Pfizer wedi cynllunio oedi yn eu cynhyrchu er mwyn ailgychwyn yn fwy effeithlon. Maen nhw'n ffyddiog bod hynny'n golygu y byddant yn cynhyrchu brechlyn ar gyfradd uwch, i gyflawni eu hymrwymiadau gyda'r contract sydd ganddyn nhw gyda Llywodraeth y DU ar gyfer pob un o'r pedair gwlad, ac yn wir eu hymrwymiadau drwy Ewrop. Mae hynny'n newyddion da ac maen nhw hefyd yn credu y byddant yn gallu negodi'r trefniadau newydd ar gyfer trosglwyddo nwyddau rhwng yr Undeb Ewropeaidd a'r DU, ac wrth gwrs mae hynny'n hynod bwysig i bob un ohonom ni hefyd. O ran eich sylw am y niferoedd y bobl dduon a lleiafrifoedd ethnig sy'n cael y brechlyn a phetruster, mae'n fater yr wyf wedi bod yn pryderu amdano o'r cychwyn cyntaf. Rydym yn ymwybodol iawn bod amrywiaeth o newyddion a chyfryngau ffug yn gysylltiedig â grŵp eang o bobl ledled y wlad. Mae rhywfaint o hynny wedi'i dargedu'n benodol at gymunedau ffydd a rhai cymunedau penodol, cymunedau du ac Asiaidd yn arbennig. Felly, rydym ni yn gwneud gwaith, nid yn unig - . Mae Llywodraethau eraill hefyd yn gwneud rhywbeth tebyg hefyd, o ran negeseuon ledled y DU, ond hefyd, yn ddiweddarach heddiw, byddaf yn ymuno â chyfarfod bord gron gydag amrywiaeth o arweinwyr cymunedol i helpu i fynd i'r afael â rhai o'r union bwyntiau hyn. Byddwch wedi clywed y sylwadau a wnes i ac a wnaeth y Prif Weinidog yn y gynhadledd i'r wasg ddoe, gan egluro sut yr hoffem ni fynd ati i wneud hyn mor agored â phosibl o ran yr hyn y mae'r Llywodraeth yn ei wneud, ond hefyd y ffordd y mae ein byrddau iechyd yn gwneud gwaith allgymorth uniongyrchol gyda rhai o'r cymunedau hyn. Ac rwy'n ddiolchgar iawn i staff gofal iechyd unigol sy'n estyn yn ôl i'w cymunedau i dynnu sylw at y ffaith bod y brechlyn yn ddiogel ac yn effeithiol, ac nad oes unrhyw rwystr iddyn nhw ei gymryd o achos safbwynt crefyddol neu darddiad ethnig, ac mae hynny'n wirioneddol bwysig i bob un ohonom ni, waeth beth fo ein gwleidyddiaeth ein hunain yn y Siambr, i ymdrin â'r newyddion ffug a fydd yn gadael pobl yn fwy agored i niwed. O ran cynlluniau ar gyfer yr ail ddos, mae hynny'n rhan bwysig o'r hyn yr ydym ni yn ei wneud; fe welwch chi fwy a mwy o bobl yn cael eu hail ddos yn yr wybodaeth a gyhoeddir bob dydd. Byddwch hefyd yn gweld cyfradd yr ail ddos yn codi ychydig. Fe roesom ni bron iawn i 700 ail ddos ddoe a chyn bo hir byddwn yn rhoi ail ddos i filoedd o bobl bob wythnos ac yna degau o filoedd wrth i ni gyrraedd y bobl hynny y mae angen iddyn nhw gael eu hail ddos Pfizer hefyd. Mae angen i ni sicrhau bod y stoc ar gael i sicrhau ein bod yn rhoi'r ail ddos gywir i bobl dros yr wythnosau i ddod. Nawr, o ran pobl 70 i 74 oed, nid wyf wedi rhoi cyfarwyddyd sy'n ei gwneud hi'n ofynnol i bobl 70 i 74 oed fynd i ganolfan frechu torfol. Mae'n debyg y byddai'n fwy defnyddiol pe gallwn i weld yr ohebiaeth neu'r awgrym yr ydych chi'n cyfeirio ato i geisio mynd i'r afael â hynny. Mae bob amser yn bosibilrwydd bod sïon ac awgrym bod Llywodraeth Cymru wedi ymyrryd pan nad ydym ni wedi gwneud hynny, a byddaf yn glir iawn nad oes dewis polisi yr wyf wedi'i wneud sy'n rhoi rheidrwydd ar bobl 70 i 74 oed fynd i ganolfan frechu torfol. Rydym ni'n mynd ati mewn modd bwriadol amrywiol, gyda 438 o leoliadau gwahanol lle gellir brechu pobl. O ran eich sylw am bobl ag anableddau dysgu, mae'n dibynnu a yw hi'n adeg iddyn nhw gael brechlyn yn y lle cyntaf, oherwydd mewn gwirionedd nid yw awdurdodiad yr Asiantaeth Rheoleiddio Meddyginiaethau a Chynhyrchion Gofal Iechyd yn cynnwys pob plentyn, fel y gwyddoch chi, ac mae hefyd yn ymwneud wedyn â phobl sy'n ofalwyr a'r rhai sy'n ofalwyr yng ngrŵp 6, a'r rhai sy'n oedolion hŷn ag anableddau dysgu hefyd. Ac mae hynny'n rhan o'r heriau yr ydym ni'n eu hystyried, o ran ein hymwneud â'r Cyd-bwyllgor ar Imiwneiddio a Brechu a'n cynrychiolwyr o Gymru ar y fforwm hwnnw, ond hefyd o ran ein cyngor ehangach ar iechyd y cyhoedd hefyd. Wrth gyflwyno i grŵp 6 yn benodol, byddwn yn gwneud rhywfaint o gyfathrebu ynghylch hynny ac yn ceisio gwneud hynny mor glir â phosibl, a bydd hynny'n llywio nid yn unig yr hyn yr ydym ni, y Llywodraeth, yn ei wneud, a'r ymwneud rhwng y byrddau iechyd â chi, yn eich swyddogaethau lleol yn Aelodau, ond mae'n amlwg y byddaf yn parhau i sicrhau bod hynny ar gael i aelodau'r pwyllgor iechyd yn y sesiynau briffio rheolaidd yr ydym yn parhau â nhw. Credaf fod hynny'n ateb y cwestiynau a ofynnwyd ar hyn o bryd.